RhumbLine Advisers’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-15,863
| Closed | -$535K | – | 3024 |
|
|
2019
Q1 | $535K | Sell |
15,863
-543
| -3% | -$18.3K | ﹤0.01% | 2308 |
|
|
2018
Q4 | $479K | Buy |
16,406
+12,754
| +349% | +$372K | ﹤0.01% | 2316 |
|
|
2018
Q3 | $225K | Sell |
3,652
-10,197
| -74% | -$628K | ﹤0.01% | 2672 |
|
|
2018
Q2 | $1.02M | Buy |
13,849
+11,371
| +459% | +$839K | ﹤0.01% | 2001 |
|
|
2018
Q1 | $163K | Sell |
2,478
-77
| -3% | -$5.07K | ﹤0.01% | 2648 |
|
|
2017
Q4 | $215K | Sell |
2,555
-518
| -17% | -$43.6K | ﹤0.01% | 2594 |
|
|
2017
Q3 | $355K | Buy |
3,073
+6
| +0.2% | +$693 | ﹤0.01% | 2490 |
|
|
2017
Q2 | $358K | Buy |
3,067
+725
| +31% | +$84.6K | ﹤0.01% | 2468 |
|
|
2017
Q1 | $289K | Buy |
2,342
+56
| +2% | +$6.91K | ﹤0.01% | 2521 |
|
|
2016
Q4 | $311K | Buy |
2,286
+337
| +17% | +$45.8K | ﹤0.01% | 2475 |
|
|
2016
Q3 | $388K | Buy |
1,949
+126
| +7% | +$25.1K | ﹤0.01% | 2350 |
|
|
2016
Q2 | $236K | Buy |
+1,823
| New | +$236K | ﹤0.01% | 2660 |
|